Medical imaging data obtained during clinical trials contains valuable data. As pharmaceutical companies consider using time-saving and efficient artificial intelligence and machine learning techniques, there are important considerations. This whitepaper discusses how these techniques can save time and how they can be implemented consistently in order to obtain useful data.
“Pharmaceutical firms face many challenges in bringing their products through clinical trials — from enrollment delays to data quality issues — and every advantage can make a difference. In image analysis, sponsors can gain a critical advantage by leveraging artificial intelligence/machine learning. Artificial intelligence (AI) and machine learning (ML) allow rapid and efficient assessment of images and can aid in more accurate identification, classification and measurement of specimens.” Read more here.
(Source: SmartBrief, 2021)